The 20 Best Small Cell Lung Cancer (SCLC) Doctors Near Me in Washington, DC

Stephen Liu is a Hematologist in Washington, Washington, D.c.. Dr. Liu is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.

Dr. Benjamin Levy is a thoracic medical oncologist and the clinical director of medical oncology for the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital, as well as an associate professor of oncology for Johns Hopkins University School of Medicine. He practices out of the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Levy is a physician scientist who is interested in innovative immunotherapeutic approaches for advanced stage lung cancer patients and biomarkers that help define those patients more likely to respond to such agents. He has an expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and thymic malignancies, as well as head and neck cancer. Dr. Levy earned his medical degree from Medical College of Georgia. He completed an internal medicine residency at Georgetown University Hospital, followed by a hematology/oncology fellowship at New York Presbyterian/Weill Cornell Medical Center, where he received the Department of Medicine Research Fellow of the Year Award and the 2009 American Society of Clinical Oncology Young Investigator Award for his clinical research in prostate cancer. Dr. Levy previously worked as an assistant professor at the Icahn School of Medicine, medical director of thoracic oncology for Mount Sinai Health Systems and associate director of the Cancer Clinical Trials Office for Mount Sinai Hospital in New York City. Dr. Levy played an integral role on several American Society of Clinical Oncology (ASCO) committees and currently serves as associate editor for the ASCO University Committee. He completed a two year term on the editorial board for the Journal of Clinical Oncology and currently serves as an ad hoc reviewer for other journals, including Clinical Lung Cancer, The Oncologist and Oncotarget. Dr. Levy was recently selected as one of only 15 oncologists in the country to the prestigious ASCO Leadership Development program, whose mission is to identify and develop future leaders of ASCO. In addition to his ASCO commitments, Dr. Levy serves on the ALLIANCE Respiratory Committee, the IASLC Staging Committee and the IASLC Career Development & Fellowship Committee. Dr. Levy is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Small Cell Lung Cancer (SCLC), and Pleuropulmonary Blastoma.

Bruce R. Kressel, M.D., is a medical oncologist at Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital and an instructor at Johns Hopkins University School of Medicine. In addition to an expertise in breast and lung cancer, Dr. Kressel has an expertise in gynecologic oncology and general medical oncology, with specific focuses on hematologic malignancies including lymphoma, leukemia and myeloma. Dr. Kressel earned his medical degree at Tufts University School of Medicine. He completed a residency in internal medicine at George Washington University School of Medicine, followed by a fellowship in hematology and oncology, also at George Washington University School of Medicine. Dr. Kressel completed a fellowship in oncology at the Georgetown Lombardi Comprehensive Cancer Center as well. Dr. Kressel has been regularly named one of America’s Top Doctors and one of America's Top Doctors for Cancer by Castle Connolly. He has also been named a Top Doctor in the Washington D.C. and Washington-Baltimore areas by Castle Connolly, as well as a Top Doctor by Consumers’ Checkbook Magazine and Washingtonian Magazine. Dr. Kressel is a member of the American Society of Clinical Oncology and the American Society of Hematology. Dr. Kressel has contributed to numerous publications, presentations and clinical trials. Dr. Kressel is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Essential Thrombocythemia, Non-Hodgkin Lymphoma, Gastric Lymphoma, Chronic Lymphocytic Leukemia (CLL), and Splenectomy.

Nitika Paudel is a Radiologist in Washington, Washington, D.c.. Dr. Paudel is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC).

Nobuyuki Takahashi is a primary care provider, practicing in Internal Medicine in Bethesda, Maryland. Dr. Takahashi is rated as an Elite provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH), and Neuroendocrine Tumor.

Aditya Halthore, MD, serves as Assistant Professor in the Department of Radiation Oncology and Molecular Radiation Sciences and Director of Safety and Quality at the Johns Hopkins University School of Medicine. Listen to Dr. Halthore's On Target podcast episode to learn more about his work. Dr. Halthore is an expert in proton therapy and specializes in genitourinary and thoracic cancers. His specific interests include prostate, bladder, lung, esophageal, and thymic cancers, and he is committed to developing personalized treatment strategies for every patient. Dr. Halthore was previously recognized as a Howard Hughes Medical Institute (HHMI)/National Institutes of Health (NIH) Scholar and his research interests include grant funded clinical trials focused on the novel utilization of radiation and imaging techniques, such as spatial fractionation (proton GRID) therapy for the treatment of bulky cancers. He is also involved in using dual-energy CT and functional MRI studies that aim to improve functional radiation planning and the assessment of radiation-induced changes. As an educator, Dr. Halthore serves as Course Director for the Johns Hopkins Proton Therapy Certificate Program. He actively participates in student, resident, and fellow lectureship and mentorship across the Johns Hopkins health system. Dr. Halthore participates in several national-level initiatives including as a member of the American Society of Therapeutic Radiation Oncology (ASTRO) Guidelines Subcommittee and as a board member and ASTRO liaison to the Medical Dosimetry Certification Board (MDCB). Dr. Halthore is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Prostate Cancer, Small Cell Lung Cancer (SCLC), Marginal Zone Lymphoma (MZL), and Familial Prostate Cancer.

Peter G. Hamm, M.D., is a pulmonologist with Johns Hopkins Medicine Pulmonology. Dr. Hamm is also the chairman of the department of medicine and the chairman of the intensive care unit (ICU) committee at Sibley Memorial Hospital. Dr. has an expertise in annual physicals, acute and urgent care, disease management and pulmonary medicine. He earned his medical degree from Columbia University College of Physicians and Surgeons. He went on to complete his residency in internal medicine at St. Luke’s Hospital, followed by a fellowship in pulmonary medicine at Bellevue Hospital Center. Dr. Hamm has been named a Top Doctor in the Washington, D.C., Baltimore and Washington-Baltimore areas by Castle Connolly. He has also been named a Top MD by Consumers’ Checkbook Magazine. Dr. Hamm contributed to a publication on the diagnosis of pulmonary Kaposi’s sarcoma with fiberoptic bronchoscopy and endobronchial biopsy. Dr. Hamm is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Large-Cell Lung Carcinoma, EGFR Positive Lung Cancer, Squamous Cell Lung Carcinoma, and Lung Adenocarcinoma.

Andrew Akman, MD, MBA a native of Washington, DC, currently practices at Suburban Hospital, Sibley Hospital, and Johns Hopkins Hospital. Dr. Akman performs a variety of minimally invasive procedures. He has specific interest in complex IVC filter removals, interventional oncology, pulmonary embolism, and prostate artery embolization. Dr. Akman is an expert in complex IVC filter retrieval and IVC filter related complications. In addition to standard IVC filter retrievals, he removes devices that are severely tilted, embedded, or fractured, as well as those designated as permanent devices. He serves as an adviser to other physicians on complex techniques including laser sheath and forceps assisted retrieval. Within interventional oncology, Dr. Akman performs thermal ablation of lung, liver, and kidney tumors. He performs chemoembolization and radioembolization (Yttrium-90) on primary liver cancer and metastatic liver disease. Dr. Akman also performs prostate artery embolization, an emerging minimally invasive technique for treating urinary symptoms associated with prostate enlargement. Dr. Akman prides himself on building strong relationships with his patients and practicing patient-centered medicine. Videos Andrew Akman, M.D., Interventional Radiologist Recent News Articles and Media Coverage Honoring a Life By Helping Others, Johns Hopkins Medicine, (July 20, 2022). Dr. Akman is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Ascites, Ureterocele, Familial Pancreatic Cancer, Gastrostomy, and Liver Embolization.

Hassan Chami is a Pulmonary Medicine provider in Washington, Washington, D.c.. Dr. Chami is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Endoscopy.

Andrew Lerner, M.D., is a clinical instructor of medicine in the pulmonary and critical care medicine department at the Johns Hopkins University School of Medicine, as well as the director of interventional pulmonology at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. He practices out of Sibley Memorial Hospital in Washington, D.C. Dr. Lerner is part of the Sibley Memorial Hospital Lung Nodule and Lung Cancer Screening Clinic, the Multidisciplinary Pulmonary and Thoracic Surgery Clinic, and the Multidisciplinary Thoracic Tumor Board Conference. Dr. Lerner has an expertise in minimally invasive procedures for the early diagnosis and treatment of malignant and non-malignant diseases of the airways, lungs and pleura. He is experienced in advanced diagnostic and therapeutic bronchoscopy, including endobronchial ultrasound (EBUS) bronchoscopy, navigational bronchoscopy, rigid bronchoscopy, tumor ablative techniques, airway stent placement, airway dilation, radial EBUS, conventional transbronchial needle aspiration (TBNA), bronchial thermoplasty, whole lung lavage and percutaneous lung biopsy; as well as percutaneous tracheostomy, tunneled pleural catheter placement, thoracentesis, tube thoracoscopy, medical thoracoscopy, chemical pleurodesis and upper endoscopy (EGD/PEG) placement. Dr. Lerner earned his medical degree from George Washington University School of Medicine. He completed his residency in internal medicine at Thomas Jefferson University Hospital, followed by a fellowship in pulmonary and critical care medicine at the University of California, San Diego. Dr. Lerner then completed a two-year advanced fellowship in interventional pulmonology at The Johns Hopkins Hospital, including a chief fellowship year. He has been involved in multiple research projects in the field and completed a Science of Clinical Investigation Certificate Program at Johns Hopkins University Bloomberg School of Public Health. Dr. Lerner has been a member of the Alpha Omega Alpha medical honors society since 2011 and earned The Johns Hopkins Hospital Patient Safety Star Award in 2016. Dr. Lerner has contributed to numerous presentations, lectures, publications, book chapters and abstracts. He is a reviewer for several research journals. Dr. Lerner has various research interests and is currently involved in research projects focusing on EBUS bronchoscopy, lung cancer diagnosis and staging, and other topics. Confidential email to reach Dr. Lerner for any questions: alerner@jhu.edu. Dr. Lerner is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Nodules, Lymphofollicular Hyperplasia, Pleural Effusion, Pleurisy, and Endoscopy.

Dr. Susan Scott is a thoracic medical oncologist with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. Dr. Scott has expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and pulmonary carcinoid tumors, as well as thymic malignancies. She leads the EGFR and HER2 lung cancer research program for Johns Hopkins. Dr. Scott received her undergraduate education at the University of Oxford, UK and medical doctorate from Yale University. She completed residency at the Cleveland Clinic where she also served as Chief Resident in Internal Medicine. Dr. Scott joined Johns Hopkins Oncology for fellowship training in Baltimore and was recruited to the thoracic oncology program to continue work as a physician and clinical scientist focused in lung cancer. Dr. Scott and her team are committed to providing compassionate and individualized care to their patients, including state-of-the-art therapies and clinical trials. Her research interests include clinical trials in resectable lung cancer, innovative applications of immunotherapy, and novel targeted therapies, especially EGFR- and HER2-mutated lung cancers. Dr. Scott is a member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC). Dr. Scott is rated as an Advanced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer.

Rebecca Krochmal is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. Krochmal is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Endoscopy, and Gastrostomy. Dr. Krochmal is currently accepting new patients.

Pamela Randolph is a Radiation Oncologist in Washington, Washington, D.c.. Dr. Randolph is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Posterior Fossa Tumor, Anal Cancer, Small Cell Lung Cancer (SCLC), and Lung Cancer.

Irina Veytsman is a Hematologist and an Oncologist in Washington, Washington, D.c.. Dr. Veytsman is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and Lung Adenocarcinoma.

Eric Anderson is a Pulmonary Medicine specialist and an Intensive Care Medicine provider in Washington, Washington, D.c.. Dr. Anderson is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Large-Cell Lung Carcinoma, Squamous Cell Lung Carcinoma, and Advanced Bronchoscopy.

Chul Kim is a Hematologist in Washington, Washington, D.c.. Dr. Kim is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer, and Squamous Cell Lung Carcinoma.

Deepa Subramaniam is an Internal Medicine provider in Washington, Washington, D.c.. Dr. Subramaniam is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.

Robert Christie is an Oncologist in Arlington, Virginia. Dr. Christie is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Multiple Myeloma.

David Duhamel is an Intensive Care Medicine specialist and a Pulmonary Medicine provider in Arlington, Virginia. Dr. Duhamel is rated as a Distinguished provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Small Cell Lung Cancer (SCLC), Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Gastrostomy. Dr. Duhamel is currently accepting new patients.

"Dr. Rachit Kumar is a radiation oncologist specializing in genitourinary and gastrointestinal cancers. He is dedicated to patient-centered care, finding the most effective outcome for each patient and using the latest advances to minimize treatment time and side-effects. Dr. Kumar is frequently published in peer-reviewed journals on new methods of radiation therapy and the benefits to patient outcomes. He is a member of the Johns Hopkins Kimmel Cancer Center and treats patients at both Sibley Memorial Hospital and Suburban Hospital. Selected Publications Kumar R, Tchelebi LT, Anker CJ, Sharma N, Bianchi NA, Dragovic J, Goodman KA, Herman JM, Jiang Y, Jones WE, Kenney TJ, Lee P, Kundranda MK, Russo S, Small W, Suh WW, Yee N, and Jabbour SK. “American Radium Society (ARS) Appropriateness Use Criteria (AUC) for Loco-Regional Gastric Adenocarcinoma: Systemic Review and Guidelines.” American Journal of Clinical Oncology. 2022 Sep 1;45(9):391-402. Rooney MK, Traube B, Khan MK, Kumar R, and Walker GV. “Factors associated with image guided radiation therapy image rejection in a multi-site institution.” JCO Oncology Practice. Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, and Kuban DA. “Contemporary Prostate Cancer Treatment Choices in Multidisciplinary Clinics Referenced to National Trends.” Cancer. Tang C, Lei X, Smith GL, Pan HY, Hoffman K, Kumar R, Chapin BF, Shih YC, Frank SJ, and Smith BD. ""Influence of Geography on Prostate Cancer Treatment Coice: An Analysis of the National Medicare Database."" International Journal of Radiation Oncology Biology Physics. Tang C, Sherry AD, Haymaker C, Bathala T, Liu S, Fellman B, Aparicio A, Zurita-Saavedra A, Chun S, Reddy J, Choi S, Ghia A, McGuire S, Efstathiou E, Wang J, Wang J, Tu SM, Pilie P, Kovitz C, Kumar R, Roberts T, Borghero Y, Shi Z, Chapin B, Gomez D, Wistuba I, Corn and PG. “Addition of local consolidative therapy to intermittent hormone therapy for oligometastatic prostate cancer (EXTEND): a multicenter randomized phase II basket trial.” JAMA Oncology.". Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Small Cell Lung Cancer (SCLC). His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Pancreatoblastoma, Pancreaticoduodenectomy, and Gastrostomy.